FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’snews2024-07-02T18:58:44+00:00July 2nd, 2024|The New York Times|
Embattled Alzheimer’s Researcher Is Charged With Fraudnews2024-06-28T22:05:18+00:00June 28th, 2024|The New York Times|
Gilead Shot Provides Total Protection From HIV in Trial of Young African Womennews2024-06-21T23:30:20+00:00June 21st, 2024|The New York Times|
Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?news2024-06-17T21:59:44+00:00June 17th, 2024|The New York Times|
How A.I. Is Revolutionizing Drug Developmentnews2024-06-17T09:03:08+00:00June 17th, 2024|The New York Times|
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lillynews2024-06-10T21:05:19+00:00June 10th, 2024|The New York Times|
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefitsnews2024-06-10T09:00:35+00:00June 10th, 2024|The New York Times|
FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flawsnews2024-05-31T19:08:30+00:00May 31st, 2024|The New York Times|
What to Know About Ozempic and Other Drugs Used for Weight Lossnews2024-05-20T09:01:24+00:00May 20th, 2024|The New York Times|
FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancernews2024-05-16T20:59:45+00:00May 16th, 2024|The New York Times|
